Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Paul S. who wrote (347)	4/2/1998 11:38:00 AM
From: F. Jay Abella, III	Read Replies (2) \| Respond to of 1185

Paul: <<But don't you think if the big announcement was made that the market would value Nortran at a much higher level. (ie. like what happened with Forbes Meditech).>> Yes that is exactly what I am saying. However, without any announcement or further news, NRT is becoming appropriately valued in the low 2's (but that's still a double since early Jan)!!! That's why I start covering companies based on valuation. They can undergo massive increases in price based on what has already happened rather than what could possibly occur going forward. Then, when milestones are met, the upward movement is all the more dramatic. FJA PS - Ask is 2.10 Dear CCM: Your warrants are in the money. This is a recording.